ES2111547T3 - Comprimido de liberacion prolongada. - Google Patents

Comprimido de liberacion prolongada.

Info

Publication number
ES2111547T3
ES2111547T3 ES91112313T ES91112313T ES2111547T3 ES 2111547 T3 ES2111547 T3 ES 2111547T3 ES 91112313 T ES91112313 T ES 91112313T ES 91112313 T ES91112313 T ES 91112313T ES 2111547 T3 ES2111547 T3 ES 2111547T3
Authority
ES
Spain
Prior art keywords
component
pharmaceutically active
release tablet
powder
prolonged release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91112313T
Other languages
English (en)
Inventor
Minoru Okada
Tetsuo Hayashi
Shuichi Kasai
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2111547T3 publication Critical patent/ES2111547T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UNA TABLETA DE LIBERACION SOSTENIDA. LA TABLETA ES UNA COMBINACION DE POLVO (A) QUE COMPRENDE UN COMPONENTE DE ACEITE, UN POLIMERO INSOLUBLE EN AGUA, O AMBOS, Y UN COMPONENTE FARMACEUTICAMENTE ACTIVO Y UN POLVO (B) QUE COMPRENDE UN POLIMERO SOLUBLE EN AGUA Y UN COMPONENTE FARMACEUTICAMENTE ACTIVO. SE PUEDE ASEGURAR FACILMENTE UN NIVEL DE LIBERACION IDEAL PARA EL COMPONENTE INDIVIDUAL FARMACEUTICAMENTE ACTIVO AL CONTROLAR SU NIVEL DE LIBERACION AL CAMBIAR LA PROPORCION DE POLVOS (A) Y (B).
ES91112313T 1990-07-25 1991-07-23 Comprimido de liberacion prolongada. Expired - Lifetime ES2111547T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2197019A JP2572673B2 (ja) 1990-07-25 1990-07-25 徐放性錠剤

Publications (1)

Publication Number Publication Date
ES2111547T3 true ES2111547T3 (es) 1998-03-16

Family

ID=16367420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91112313T Expired - Lifetime ES2111547T3 (es) 1990-07-25 1991-07-23 Comprimido de liberacion prolongada.

Country Status (8)

Country Link
US (1) US5164193A (es)
EP (1) EP0468436B1 (es)
JP (1) JP2572673B2 (es)
KR (1) KR0169319B1 (es)
CA (1) CA2046845C (es)
DE (1) DE69128569T2 (es)
ES (1) ES2111547T3 (es)
TW (1) TW222592B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
PL351948A1 (en) * 1999-06-04 2003-07-14 Alza Corp Implantable gel compositions and method of making thereof
WO2001015665A1 (en) 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
WO2002067905A1 (en) * 2001-02-27 2002-09-06 Kos Pharmaceuticals, Inc. A sustained release pharmaceutical formulation
KR100464592B1 (ko) * 2001-04-13 2004-12-31 주식회사 한국팜비오 포타슘시트레이트를 함유한 왁스 매트릭스 타입의 정제와그의 조성물
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CN1610551A (zh) * 2001-07-06 2005-04-27 恩德制药公司 用作止痛剂的6－羟基羟吗啡酮的肠胃外给药
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
RU2190408C1 (ru) * 2001-10-16 2002-10-10 Нестерук Владимир Викторович Лекарственное средство на основе пентоксифиллина
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
US20050031686A1 (en) * 2002-03-25 2005-02-10 Truffini & Regge' Farmaceutici Srl Gastroresistant tablets for alimentary, dietetic and therapeutic use
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20090060993A1 (en) * 2007-09-04 2009-03-05 Joseph Schwarz Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
JP5122380B2 (ja) * 2008-06-16 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の放出を制御した速崩錠及びその製法
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
CN109219442A (zh) 2016-04-04 2019-01-15 Omeza有限公司 鱼油局部组合物
CA3084953A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
AU2018378348B2 (en) 2017-12-05 2024-09-19 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
EP0468436A1 (en) 1992-01-29
CA2046845C (en) 2001-03-27
DE69128569T2 (de) 1998-04-16
TW222592B (es) 1994-04-21
EP0468436B1 (en) 1998-01-07
JP2572673B2 (ja) 1997-01-16
KR930001899A (ko) 1993-02-22
DE69128569D1 (de) 1998-02-12
CA2046845A1 (en) 1992-01-26
JPH0482825A (ja) 1992-03-16
KR0169319B1 (ko) 1999-01-15
US5164193A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
ES2111547T3 (es) Comprimido de liberacion prolongada.
ATE232091T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
ATE324872T1 (de) Orale pharmazeutische zusammensetzung mit verzögerter wirkstofffreigabe von protonenpumpen- hemmern
ECSP034455A (es) Forma de dosificacion de farmaco activada por hidrogel
BR0107869A (pt) Composições farmacêuticas eletrogiradas
DK1244401T3 (da) Medikamentdosering af faseændrende formulering
DE60023107D1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
ES2128369T3 (es) Procedimiento para la fabricacion de formas farmaceuticas solidas con liberacion prolongada en dos etapas.
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
ES2052016T3 (es) Composicion emulsionada.
CA2177772A1 (en) Pharmaceutical compositions containing irbesartan
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
EA200001201A3 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
EA200200207A1 (ru) Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
DE69928815D1 (de) Dosierungsform mit flüssiger formulierung
BR9809571A (pt) Composição medicinal e processo para produzì-la
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
AU3080392A (en) Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms
BG108870A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
BR0314804A (pt) Forma de dosagem de liberação modificada
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468436

Country of ref document: ES